Innovative Medicines Canada has an effective and engaged Board of Directors that enables member companies to achieve common objectives.
Frédéric Fasano, Servier Canada Inc.
John Helou, Pfizer Canada Inc.
Allison Rosenthal, Otsuka Canada Pharmaceutical Inc. (OCPI)
Jamie Freedman, AstraZeneca Canada Inc.
Chris Halyk, Janssen Inc.
Brian Hilberdink, Novo Nordisk Canada Inc.
Alok Kanti, Bayer Inc.
Stéphane Lassignardie, AbbVie Corporation
Lisa Matar, Eli Lilly Canada Inc.
Ronnie Miller, Hoffmann-La Roche Limited
Janice Murray, Novartis Pharmaceuticals Canada Inc.
Anna van Acker, Merck Canada Inc.